Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 25;9(3):524.
doi: 10.3390/cells9030524.

Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope

Khushboo S Gala  1 , Vatsalya Vatsalya  2   3
Affiliations
Review

Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope

Khushboo S Gala et al. Cells. .

Abstract

Alcohol use disorder is associated with a wide array of hepatic pathologies ranging from steatosis to alcoholic-related cirrhosis (AC), alcoholic hepatitis (AH), or hepatocellular carcinoma (HCC). Biomarkers are categorized into two main categories: biomarkers associated with alcohol consumption and biomarkers of alcoholic liver disease (ALD). No ideal biomarker has been identified to quantify the degree of hepatocyte death or severity of AH, even though numerous biomarkers have been associated with AH. This review provides information of some of the novel and latest biomarkers that are being investigated and have shown a substantial association with the degree and severity of liver injury and inflammation. Importantly, they can be measured noninvasively. In this manuscript, we consolidate the present understanding and prospects of these biomarkers; and their application in assessing the severity and progression of the alcoholic liver disease (ALD). We also review current and upcoming management options for AH.

Keywords: alcohol; alcoholic hepatitis; alcoholic liver disease; medical management; noninvasive biomarkers; novel biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dang K., Hirode G., Singal A.K., Sundaram V., Wong R.J. Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases. Am. J. Gastroenterol. 2020;115:96–104. doi: 10.14309/ajg.0000000000000380. - DOI - PubMed
    1. Thursz M., Kamath P.S., Mathurin P., Szabo G., Shah V.H. Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study. J. Hepatol. 2019;70:521–530. doi: 10.1016/j.jhep.2018.10.041. - DOI - PubMed
    1. Grant B.F., Dufour M.C., Harford T.C. Epidemiology of alcoholic liver disease. Proc. Semin. Liver Dis. 1988;8:12–25. doi: 10.1055/s-2008-1040525. - DOI - PubMed
    1. Vatsalya V., Hassan H.Z. Liver Diseases. Springer International Publishing; Basel, Switzerland: 2020. Alcoholic Liver Disease.
    1. Savolainen V.T., Liesto K., Männikkö A., Penttilä A., Karhunen P. Alcohol consumption and alcoholic liver disease: Evidence of a threshold level of effects of ethanol. Alcohol. Clin. Exp. Res. 1993;17:1112–1117. doi: 10.1111/j.1530-0277.1993.tb05673.x. - DOI - PubMed

Publication types

LinkOut - more resources